US Biosimilar Sponsors Seek Off-The-Record Discussions
Biosimilar Sponsors Want Off-The-Record Labeling Discussions With FDA
Hoping to avoid litigation discovery, sponsors ask FDA for avenue to explain patent issues during labeling discussions without written record; negotiations for BsUFA III may be opportunity to create such a process.